ZA842562B - Ph independent controlled release tablets - Google Patents

Ph independent controlled release tablets

Info

Publication number
ZA842562B
ZA842562B ZA842562A ZA842562A ZA842562B ZA 842562 B ZA842562 B ZA 842562B ZA 842562 A ZA842562 A ZA 842562A ZA 842562 A ZA842562 A ZA 842562A ZA 842562 B ZA842562 B ZA 842562B
Authority
ZA
South Africa
Prior art keywords
controlled release
dipyridamole
acid
release tablets
independent controlled
Prior art date
Application number
ZA842562A
Other languages
English (en)
Inventor
Jung-Yong Park
Jerzy Debski
Kieran G Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of ZA842562B publication Critical patent/ZA842562B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA842562A 1983-04-08 1984-04-05 Ph independent controlled release tablets ZA842562B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08

Publications (1)

Publication Number Publication Date
ZA842562B true ZA842562B (en) 1985-12-24

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA842562A ZA842562B (en) 1983-04-08 1984-04-05 Ph independent controlled release tablets

Country Status (20)

Country Link
EP (1) EP0121901B1 (da)
JP (1) JPS6034906A (da)
KR (1) KR880002139B1 (da)
AT (1) ATE32980T1 (da)
AU (1) AU570446B2 (da)
CA (1) CA1219216A (da)
DD (1) DD222496A5 (da)
DE (1) DE3469848D1 (da)
DK (1) DK166259C (da)
ES (1) ES531346A0 (da)
FI (1) FI82604C (da)
GR (1) GR81907B (da)
HU (1) HU191542B (da)
IE (1) IE57220B1 (da)
IL (1) IL71458A (da)
NO (1) NO164958C (da)
NZ (1) NZ207768A (da)
PH (1) PH21585A (da)
PT (1) PT78380B (da)
ZA (1) ZA842562B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
MX2008002492A (es) * 2005-08-22 2008-04-03 Novartis Ag Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
CA2671470C (en) 2006-12-13 2012-05-01 F. Hoffmann-La Roche Ag Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
DD222496A5 (de) 1985-05-22
NO164958C (no) 1990-12-05
FI841369A0 (fi) 1984-04-06
NO841372L (no) 1984-10-09
EP0121901B1 (en) 1988-03-16
FI82604C (fi) 1991-04-10
HU191542B (en) 1987-03-30
NO164958B (no) 1990-08-27
GR81907B (da) 1984-12-12
JPS6034906A (ja) 1985-02-22
KR880002139B1 (ko) 1988-10-17
IE840856L (en) 1984-10-08
HUT34345A (en) 1985-03-28
DK181084D0 (da) 1984-04-06
FI82604B (fi) 1990-12-31
KR840008588A (ko) 1984-12-17
PH21585A (en) 1987-12-11
DE3469848D1 (en) 1988-04-21
FI841369A (fi) 1984-10-09
EP0121901A1 (en) 1984-10-17
PT78380B (en) 1986-08-14
ATE32980T1 (de) 1988-04-15
AU570446B2 (en) 1988-03-17
DK166259C (da) 1993-08-23
IL71458A0 (en) 1984-07-31
ES8601687A1 (es) 1985-11-01
NZ207768A (en) 1987-02-20
IL71458A (en) 1987-09-16
DK166259B (da) 1993-03-29
PT78380A (en) 1984-05-01
JPH0521892B2 (da) 1993-03-25
DK181084A (da) 1984-10-09
ES531346A0 (es) 1985-11-01
IE57220B1 (en) 1992-06-03
CA1219216A (en) 1987-03-17
AU2660984A (en) 1984-10-11

Similar Documents

Publication Publication Date Title
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
JPS57159772A (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives, acid addition salts, manufacture and medicinal composition containing them
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
IL83510A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
EP0257786A3 (en) Dosage form for delivering acid sensitive beneficial agent
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
IL83032A0 (en) Pharmaceutical compositions containing calcium salts and their preparation
JPS57144219A (en) Azobissalicylic acid and salts thereof and medicinal composition containing them
GB2064514B (en) Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
DE3469848D1 (en) Ph independent controlled releasable tablets
EP0239015A3 (en) Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter
IL84344A0 (en) Pharmaceutical compositions comprising ibuprofen and tizanidine or salts thereof and their preparation
IL93590A0 (en) Acid addition salts of naphthalenmethanamino and pharmaceutical compositions containing them
IL74616A0 (en) Substituted isochromanes and benzoxepines,and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
PH25927A (en) 3,4-dihydroisoquinolinylacetic acid derivatives and pharmaceutical composition containing these compounds
IL85856A0 (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2,its acid addition salts and pharmaceutical compositions containing them
ZA818149B (en) 2-hydroxy-5-(2',4'-difluorophenyl)-benzoic acid derivatives,methods for their preparation,use thereof as pharmacologically active agents and pharmaceutical compositions containing them
IL76579A0 (en) Octahydroindolo(2,3-a)quinoli-zin-1-yl-alkanecarboxylic acid amides and their acid addition salts,their preparation and pharmaceutical compositions containing them